Poor glycaemic control, indicated by an elevated HbA1c, is correlated to poor postoperative outcome in patients with diabetes mellitus undergoing surgery. However, improving glycaemic control before surgery has not been extensively studied so far.…
ID
Bron
Verkorte titel
Aandoening
diabetes mellitus
preoperative
glucose
glycaemic control
suikerziekte
preoperatief
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary endpoint of the study will be the number of days at home up to 30 days after surgery (DAH30), which is a single,
pragmatic, patient-centred outcome.
Achtergrond van het onderzoek
Poor glycaemic control, indicated by an elevated HbA1c, is correlated to poor postoperative outcome in patients
with diabetes mellitus undergoing surgery. However, improving glycaemic control before surgery has not been
extensively studied so far. We hypothesise that improving glycaemic control, using an individualised approach
guided by a specialised diabetes care nurse, will improve postoperative outcomes, measured as number of days
spent at home in the thirty days after surgery.
In general, this study will provide more insight in the importance of glycaemic control before surgery and its ability
to improve postoperative outcomes.
Doel van het onderzoek
Poor glycaemic control, indicated by an elevated HbA1c, is correlated to poor postoperative outcome in patients with diabetes mellitus undergoing surgery. However, improving glycaemic control before surgery has not been extensively studied so far. We hypothesise that improving glycaemic control, using an individualised approach guided by a specialised diabetes care nurse, will improve postoperative outcomes, measured as number of days spent at home in the thirty days after surgery.
Onderzoeksopzet
- Preoperative consultation: blood glucose, HbA1c, fructosamine, 1,5 AG
- Day of surgery: blood glucose, HbA1c, fructosamine, 1,5 AG.
- 30 days after surgery: number of days at home up to 30 days after surgery
Onderzoeksproduct en/of interventie
On the day of preoperative consultation, HbA1c will be measured. Patients with an HbA1c <53 mmol/mol will proceed to surgery
according to standard care. Patients with an HbA1c >=53 mmol/mol will be randomised to an intervention group or control group.
Patients in the intervention group will be contacted by a diabetes care nurse for optimisation of their glycaemic control before
surgery. Patients in the control group will proceed to surgery according to standard care.
Publiek
Postbus 22660
A.H. Hulst
Amsterdam 1100 DD
The Netherlands
0615222469
a.h.hulst@amc.uva.nl
Wetenschappelijk
Postbus 22660
A.H. Hulst
Amsterdam 1100 DD
The Netherlands
0615222469
a.h.hulst@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Diabetes mellitus type 2 (diagnosis at least 3 months prior to pre-operative screening)
- Age 18 - 85 years
- Elective non-cardiac surgery
- Scheduled for surgery at least 7 days from date of screening
- Informed consent
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- Bariatric surgery
- Palliative surgery
- Outpatient or day case surgery
- (Potentially) pregnant or breast-feeding
- Unable to communicate in Dutch or English, psychiatric disorder, known therapy incompliance or deemed unfit
by the researchers for another reason
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL7288 |
| NTR-old | NTR7497 |
| Ander register | 67034 : ABR |